Medicare Enrolled

Dr. Matthew Agan, M.D.

Neurology · Marietta, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
780 CANTON RD NE STE 400, Marietta, GA 30060
7704883602
In practice since 2013 (13 years)
NPI: 1013250679 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Agan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Agan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Agan

Dr. Matthew Agan is a neurology specialist in Marietta, GA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Agan performed 668 Medicare services across 589 unique beneficiaries.

Between the years covered by Open Payments, Dr. Agan received a total of $5,478 from 51 pharmaceutical and/or device companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Agan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 39% volume in GA $5,478 industry payments

Medicare Practice Summary

Medicare Utilization ↗
668
Medicare services
Top 39% in GA for neurology
589
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~51 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
291 $62 $199
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
77 $77 $248
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
65 $103 $341
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
45 $43 $142
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
40 $59 $182
VEEG monitoring, 12-26 hours with review
This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report.
33 $163 $500
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $99 $292
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
21 $121 $383
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
20 $40 $92
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
18 $96 $256
EEG brain wave test, 61-119 minutes
This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes.
12 $68 $212
Video EEG monitoring, 2-12 hours
This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report.
11 $101 $281
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
11 $44 $142
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,478
Total received (2018-2024)
Avg $783/year across 7 years
Top 36% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
270
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,457 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,209
2023
$1,414
2022
$674
2021
$840
2020
$295
2019
$724
2018
$323

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$210
Celgene Corporation
$185
LivaNova USA, Inc.
$151
UCB, Inc.
$118
PFIZER INC.
$111
ACADIA Pharmaceuticals Inc
$70
EMD Serono, Inc.
$58
ARGENX US, INC.
$52
Amgen Inc.
$51
NEUROPACE, INC.
$41
GE HEALTHCARE
$33
Lilly USA, LLC
$32
JAZZ PHARMACEUTICALS INC.
$28
Sumitomo Pharma America, Inc.
$27
Neurocrine Biosciences, Inc.
$22
MITSUBISHI TANABE PHARMA AMERICA, INC.
$20
Top 3 companies account for 45.1% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$549
UCB, Inc.
$497
Celgene Corporation
$340
JAZZ PHARMACEUTICALS INC.
$332
ACADIA Pharmaceuticals Inc
$316
ABBVIE INC.
$265
Amgen Inc.
$263
PFIZER INC.
$231
Teva Pharmaceuticals USA, Inc.
$216
EMD Serono, Inc.
$203
Novartis Pharmaceuticals Corporation
$201
Supernus Pharmaceuticals, Inc.
$163
LivaNova USA, Inc.
$151
Biohaven Pharmaceuticals, Inc.
$143
UPSHER-SMITH LABORATORIES LLC
$134
ARGENX US, INC.
$128
Biogen, Inc.
$118
Lundbeck LLC
$97
Neurelis, Inc.
$82
Lilly USA, LLC
$78
Alexion Pharmaceuticals, Inc.
$71
W. L. Gore & Associates, Inc.
$68
Neurocrine Biosciences, Inc.
$64
Horizon Therapeutics plc
$61
Sumitomo Pharma America, Inc.
$51
Avion Pharmaceuticals
$46
Promius Pharma LLC
$44
NEUROPACE, INC.
$41
MITSUBISHI TANABE PHARMA AMERICA, INC.
$38
EISAI INC.
$36
Allergan Inc.
$35
GE HEALTHCARE
$33
Janssen Pharmaceuticals, Inc
$30
Upsher-Smith Laboratories LLC
$29
Allergan, Inc.
$29
GE HealthCare
$26
Impax Laboratories, Inc.
$26
TG THERAPEUTICS, INC.
$25
BANNER LIFE SCIENCES, LLC
$23
Boston Scientific Corporation
$23
Acorda Therapeutics, Inc
$21
Biohaven Pharmaceutical Holding Company Ltd.
$18
Octapharma USA, Inc.
$18
CSL Behring
$17
Scilex Pharmaceuticals Inc.
$17
Cala Health, Inc.
$15
Otsuka America Pharmaceutical, Inc.
$14
Avanir Pharmaceuticals, Inc.
$14
Jazz Pharmaceuticals Inc.
$13
US WorldMeds, LLC
$13
Adamas Pharmaceuticals, Inc.
$12
Top 3 companies account for 25.3% of all-time payments
Associated products mentioned in payments ›
AFINITOR · AIMOVIG · AJOVY · AMYVID · APTIOM · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Briviact · CALA TRIO · CARDIOFORM Septal Occluder · COMIRNATY · DUOPA · Dhivy · EMGALITY · EPIDIOLEX · EkoSonic · Fintepla · Fycompa · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · Hizentra · INBRIJA · INGREZZA · MAVENCLAD · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · ONGENTYS · PANZYGA · PLEGRIDY · Ponvory · QULIPTA · RADICAVA · REXULTI · RNS Neurostimulator Kit · RYTARY · SOLIRIS · SPINRAZA · Soliris · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Xadago · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Marietta?
Compare neurologists in the Marietta area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
219
Per 100K population
28.5
County median income
$98,712
Nearest hospital
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Agan is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Agan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Agan performed 291 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Agan receive payments from pharmaceutical companies?
Yes. Dr. Agan received a total of $5,478 from 51 companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Agan's costs compare to other neurologists in Marietta?
Dr. Agan's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Agan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →